Epidemiology of HIV-associated malignancies.
Dal Maso
L
L
Servizio di Epidemiologia, Centro di Riferimento Oncologico & Servizio di Epidemiologia delle Malattie Infettive, I.R.C.C.S. Lazzaro Spallanzani.
Serraino
D
D
Franceschi
S
S
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001005:Anus Neoplasms / Q000453:epidemiology; D001315:Australia / Q000453:epidemiology; D002648:Child; D015897:Comorbidity; D003906:Developing Countries; D005060:Europe / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology*; D006679:HIV Seropositivity / Q000453:epidemiology; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology; D008175:Lung Neoplasms / Q000453:epidemiology; D008228:Lymphoma, Non-Hodgkin / Q000453:epidemiology*; D008297:Male; D012042:Registries; D012107:Research Design; D012306:Risk; D012514:Sarcoma, Kaposi / Q000453:epidemiology* / Q000517:prevention & control; D012878:Skin Neoplasms / Q000453:epidemiology*; D013019:South Africa / Q000453:epidemiology; D013736:Testicular Neoplasms / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology
D019380:Anti-HIV Agents